13F Holdings
中文EN

PREM Premier Air Charter Holdings Inc.

Surgical & Medical Instruments & Apparatus · OTC · SEC CIK 1570937 · Fiscal year ends 12/31

Financial factors as of 2026-03-31 (2026Q1), TTM = sum of the last four quarters

Growth

TTM revenue YoY60.1%
TTM net income YoY-29.4%
TTM EPS YoY0.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin11.4%
Operating margin-7.8%
Net margin-11.4%
FCF margin-3.5%
EBITDA margin-4.6%

Returns

ROE-26,025.5%
ROA-11.4%
ROIC (approx.)-55.6%
Asset turnover0.99x

Leverage & solvency

Liabilities / assets92.7%
Debt / equity1.37x
Current ratio0.24x
Interest coverage-1.73x

Cash quality & payout

Operating cash flow / net income-0.28x
Accruals ratio-14.5%
Payout ratio—
Capex / revenue6.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20242024-03-31FY20242023-12-31FY20232023-03-31
Income statement
Revenue$31.88M$20.75M—$20.18M—
Cost of revenue$28.49M$18.36M—$17.03M—
Gross profit$3.39M$2.39M—$3.16M—
SG&A expense$4.38M$1.99M$99,578$1.64M$96,150
Operating income-$2.70M-$1.15M-$181,178-$259,762-$457,540
Interest expense$1.36M$854,207$125,169$82,838$195,528
Pretax income——-$398,885—-$1.75M
Income tax$0$0—$0—
Net income-$3.87M-$2.19M-$398,885-$144,823-$1.75M
EBITDA-$1.95M-$930,091—-$243,061—
EPS (basic)-0.01-0.01—0.00—
EPS (diluted)-0.01-0.01—0.00—
Weighted avg. shares (diluted)272.30M237.87M—237.87M—
Balance sheet
Cash & equivalents$213,175$225,228$325,716$129,871$28,897
Receivables$2.90M$352,944—$310,975—
Current assets$3.73M$997,117$10,798$918,027$36,877
PP&E, net$8.41M$6.44M—$89,470—
Total assets$36.05M$27.75M$10,798$6.94M$36,877
Current liabilities$16.33M$5.36M$193,428$2.15M$183,067
Short-term debt$4.04M$166,410—$10,181—
Long-term debt$0$3.67M—$81,875—
Total debt$4.04M$3.84M—$92,056—
Total liabilities$32.08M$29.31M$193,428$5.46M$183,067
Shareholders' equity$3.97M-$1.56M$1.54M$1.48M-$146,190
Net debt$3.82M$3.61M—-$37,815—
Shares outstanding280.85M237.87M30.24M237.87M24.69M
Cash flow statement
Operating cash flow$1.15M$3.09M-$117,099$255,077-$142,020
Capital expenditure$2.55M$1.49M—$45,078—
Free cash flow-$1.40M$1.60M—$209,999—
Investing cash flow-$2.82M-$928,554—-$45,078—
Financing cash flow$1.65M-$2.07M$92,500-$752,473$150,000
Depreciation & amortization$744,557$221,259—$16,701—
Stock-based compensation$42,500$0———

Free plan shows the latest 5 periods; Pro shows all 14 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.